Association of SRD5A2 Genotype and Pathological Characteristics of Prostate Tumors
JM Jaffe, SB Malkowicz, AH Walker, S MacBride… - Cancer research, 2000 - AACR
The enzyme product of SRD5A2, 5α-reductase type II, is responsible for converting
testosterone to the more metabolically active dihydrotestosterone. Therefore, SRD5A2 may …
testosterone to the more metabolically active dihydrotestosterone. Therefore, SRD5A2 may …
[引用][C] Association of SRD5A2 genotype and pathological characteristics of prostate tumors
JM JAFFE, SB MALKOWICZ… - Cancer research …, 2000 - pascal-francis.inist.fr
Association of SRD5A2 genotype and pathological characteristics of prostate tumors CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Association of SRD5A2 genotype and pathological characteristics of prostate tumors.
JM Jaffe, SB Malkowicz, AH Walker, S MacBride… - Cancer …, 2000 - europepmc.org
The enzyme product of SRD5A2, 5alpha-reductase type II, is responsible for converting
testosterone to the more metabolically active dihydrotestosterone. Therefore, SRDSA2 may …
testosterone to the more metabolically active dihydrotestosterone. Therefore, SRDSA2 may …
[引用][C] Association of SRD5A2 genotype and pathological characteristics of prostate tumors
J JM - Cancer Res, 2000 - cir.nii.ac.jp
Association of SRD5A2 genotype and pathological characteristics of prostate tumors
JM Jaffe, SB Malkowicz, AH Walker… - Cancer …, 2000 - pubmed.ncbi.nlm.nih.gov
The enzyme product of SRD5A2, 5alpha-reductase type II, is responsible for converting
testosterone to the more metabolically active dihydrotestosterone. Therefore, SRDSA2 may …
testosterone to the more metabolically active dihydrotestosterone. Therefore, SRDSA2 may …